Zinzino Expands Its Omega-3 Production Through New Investment in Xion International Group

Zinzino's Strategic Acquisition of Xion International Group



In a notable move towards securing sustainable resources, Zinzino AB has officially acquired 35% of Xion International Group, a company based in Andorra known for its innovative approaches to algae production. This acquisition, which was confirmed on July 11, 2025, marks a significant milestone for Zinzino as it aims to bolster its production capabilities for its popular omega-3 oil and spirulina products.

Background of the Acquisition


Zinzino's decision to invest in Xion aligns with its commitment to meet the ever-growing global demand for its flagship product, BalanceOil+, a dietary supplement that balances omega levels in the body. The partnership with Xion is not just about acquisition; it represents a strategic joint venture focused on creating efficient cultivation methods for microalgae using advanced bioreactors.

Xion International Group is recognized for its cutting-edge biotechnological achievements, particularly its patented photobioreactor systems designed for sustainable microalgae production. This aligns perfectly with Zinzino's goal of providing high-quality, eco-friendly nutritional supplements.

Financial Details


The agreement for the acquisition amounts to EUR 1.2 million, broken down into a cash payment of EUR 0.7 million financed by Zinzino’s cash reserves, with the remainder settled through newly issued Zinzino shares. This strategic financial planning exemplifies Zinzino's commitment to enhancing its operational capabilities without compromising its financial health.

Advancing Technology for Sustainability


According to Zinzino's CEO, Dag Bergheim Pettersen, the collaboration with Xion is pivotal for gaining a crucial raw material resource while minimizing their ecological footprint. The technology utilized by Xion is based on natural principles, ensuring that their production processes are both sustainable and efficient. This acquisition enables Zinzino to not only protect its brand but also to expand its range of health supplements based on cutting-edge nutritional science.

The partnership will pave the way for the establishment of PhytoFerm, a specialized company focusing on sustainable omega-3 production from algae, where Zinzino will hold 55% of the shares. This new entity will leverage both innovative photobioreactor and fermentation technologies to create top-tier omega-3 oils, which are essential for modern dietary needs.

Future Projections


With Xion's annual turnover at approximately EUR 1.3 million, the partnership offers Zinzino an advantageous position for expansion into new market territories and product ranges. The strategy moving forward is to enhance distribution power and secure raw materials that go beyond its current offerings.

This acquisition not only emphasizes Zinzino's continuous efforts in sustainable practices but also highlights the increasing trend of companies pivoting towards eco-friendly solutions in the health and nutrition industry.

Conclusion


In conclusion, Zinzino's stake in Xion International Group marks a transformative step in the company’s trajectory towards becoming a leader in the omega-3 market. As the demand for sustainable and scientifically-backed health products rises, Zinzino's initiative promises to not only meet consumer needs but also contribute positively to the environment. With the combined expertise and innovative technologies from both companies, PhytoFerm is set to redefine standards in the nutritional supplement industry. Expect exciting developments from this strategic alliance in the near future.

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.